Dopamine D2 receptor-mediated G protein activation assessed by agonist-stimulated [35S]guanosine 5′-O-(γ-thiotriphosphate) binding in rat striatal membranes-Reference-Cited by-同舟云学术

Dopamine D2 receptor-mediated G protein activation assessed by agonist-stimulated [35S]guanosine 5′-O-(γ-thiotriphosphate) binding in rat striatal membranes

Published:2006-09 Issue:7 Volume:30 Page:1304-1312
ISSN:0278-5846
Container-title:Progress in Neuro-Psychopharmacology and Biological Psychiatry
language:en
Short-container-title:Progress in Neuro-Psychopharmacology and Biological Psychiatry

Author:

Odagaki Yuji,Toyoshima Ryoichi

Publisher

Elsevier BV

Subject

Biological Psychiatry,Pharmacology

Reference49 articles.

1. Dopamine agonists in schizophrenia: a review;Benkert;Eur Neuropsychopharmacol Suppl,1995

2. Differences in the ligand binding properties of the short and long versions of the D2 dopamine receptor;Castro;J Neurochem,1993

3. Molecular diversity of the dopamine receptors;Civelli;Annu Rev Pharmacol Toxicol,1993

4. Partial brain dopamine D2 receptor agonists in the treatment of schizophrenia;Coward;Psychopharmacol Bull,1989

5. Characterization of Gs activation by dopamine D1 receptors using an antibody capture assay: antagonist properties of clozapine;Cussac;Eur J Pharmacol,2004

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Agonistic properties of a series of psychotropic drugs at 5-HT1A receptors in rat and human brain membranes determined by [35S]GTPγS binding assay;Pharmacological Reports;2023-01-13

2. Characterization of dopamine D2 receptor coupling to G proteins in postmortem brain of subjects with schizophrenia;Pharmacological Reports;2021-07-01

3. Acute and subchronic PCP attenuate D2 autoreceptor signaling in substantia nigra dopamine neurons;European Neuropsychopharmacology;2019-03

4. Effect of in vivo exposure to ambient fine particles (PM 2.5 ) on the density of dopamine D 2 -like receptors and dopamine-induced [ 35 S]-GTPγS binding in rat prefrontal cortex and striatum membranes;Environmental Toxicology and Pharmacology;2018-06

5. Glutamate Pharmacological Models Relevant to Schizophrenia and Psychosis;Handbook of Behavioral Neuroscience;2016